1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Solasia Pharma K.K.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study of SP-02L in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) SP-02L (darinaparsin for injection) - Peripheral T-Cell Lymphoma | Phase 2 | Completed | Solasia Pharma K.K. | 67 | 2016-03-25 | 2024-01-26 |
Lymphoma, T-Cell, Peripheral (1)
Injections (1) · darinaparsin (1)
Hong Kong (1) · Japan (1) · South Korea (1) · Taiwan (1)